Andrew F. Shorr

Andrew F. Shorr is a prominent researcher in infectious diseases and critical care medicine affiliated with Washington Hospital Center, with extensive collaborations at University of Health Sciences and Pharmacy and Washington University School of Medicine. His work focuses on hospital-acquired infections, particularly ventilator-associated pneumonia, sepsis, and antibiotic resistance patterns in critical care settings.

Dr. Shorr's research interests center on the epidemiology and management of infectious complications in intensive care units, with particular expertise in viral and bacterial pneumonia, sepsis outcomes, and antimicrobial resistance. His work has significantly contributed to understanding the role of viruses in ventilator-associated pneumonia and the impact of inappropriate antibiotic therapy on patient outcomes in severe infections.

Analysis of his publication trends reveals a consistent focus on hospital epidemiology, with recent work emphasizing viral pathogens in respiratory infections and the complex interplay between antibiotic resistance patterns and patient outcomes in critical care. His research has evolved from primarily bacterial infection studies to increasingly incorporate viral epidemiology and mixed infection patterns.

Dr. Shorr has contributed significantly to clinical understanding of infection management in intensive care through numerous collaborative studies with colleagues including Scott T. Micek and Marin H. Kollef, with research spanning appropriate antibiotic selection, mortality prediction, and resource utilization in severe infections.